NCT02229864View on ClinicalTrials.gov

Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 1, 2019

Conditions
Coronary Artery DiseaseCoronary Artery StenosisCoronary DiseaseCoronary Stenosis
Interventions
DEVICE

Coronary artery stenting: Absorb BVS

"* Scaffold diameters: 2.5, 3.0 and 3.5 mm~* Scaffold lengths: 8, 12, 18, and 28 mm"

Trial Locations (2)

49770

Cardiac & Vascular Research Center of Northern Michigan, Petoskey

85258

Scottsdale Healthcare, Scottsdale

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT02229864 - Pharmacokinetics of Everolimus in Absorb BVS in Patients With Coronary Artery Lesions | Biotech Hunter | Biotech Hunter